| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/19/2009 | CN101511354A Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders |
| 08/19/2009 | CN100528886C Metal complex with liriodenine as ligand and its synthesis process and use |
| 08/19/2009 | CN100528879C S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 08/19/2009 | CN100528878C Tetrahydroquinoline derivatives and a process for preparing the same |
| 08/19/2009 | CN100528871C Benzothiazole derivatives as adenosine receptor ligands |
| 08/19/2009 | CN100528164C Statin therapy for enhancing cognitive maintenance |
| 08/18/2009 | US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide |
| 08/18/2009 | US7576213 Vinylogous 4H-pyrones and their use in promoting plant growth |
| 08/18/2009 | US7576210 side effects reduction; treating an obstructive disease of the respiratory tract or for treating overactive bladder; 3-oxa-9-azatricyclo(3.3.1.0(2,4)nonane derivatives; 6 beta ,7 beta -epoxy-3 beta -hydroxy-8-ethoxycarbonylmethyl-8-methyl-1 alpha H,5 alpha H-tropanium bromide, di-2-thienylglycolate |
| 08/18/2009 | US7576202 Introducing tritium label by isotope exchange associated with the obtainment of a stably-traced radioactive preparation which can be used for receptor binding assay; stability |
| 08/18/2009 | US7576119 Supports such as glass and styrene polymers functionalized with tricyclic hetercyclic anhydrides and imides, used in the preparation of oligonucleotides |
| 08/18/2009 | US7576092 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 08/18/2009 | US7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 08/18/2009 | US7576088 Benzodioxole derivatives |
| 08/18/2009 | US7576085 Imidazo[1,2-a]pyrazine compounds; cancers |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2427831C Cyclization process step in the making of quinolones and naphthyridines |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2362760C Camptothecin derivatives having antitumor activity |
| 08/18/2009 | CA2239282C Fused isoindolones as inhibitors of protein kinase c |
| 08/13/2009 | WO2009100282A1 Furo-and thieno[3,2-c] pyridines |
| 08/13/2009 | WO2009100171A1 Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 08/13/2009 | WO2009099982A1 2-aminopyridine kinase inhibitors |
| 08/13/2009 | WO2009099625A2 Cyclopamine tartrate salt and uses thereof |
| 08/13/2009 | WO2009099177A1 Amino imidazole derivative |
| 08/13/2009 | WO2009098116A1 9-substituted camptothecin derivatives as antitumor compounds |
| 08/13/2009 | WO2009032754A3 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 08/13/2009 | US20090203725 Androgen Receptor Modulator Compounds and Methods |
| 08/13/2009 | US20090202536 Antibody-drug conjugates and methods |
| 08/13/2009 | CA2711078A1 Furo- and thieno[3,2-c] pyridines |
| 08/12/2009 | EP2086643A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 08/12/2009 | EP1509529B1 Esters in position 20 of camptothecins |
| 08/12/2009 | CN101506185A Tetrahydrofuro [3, 2-B] pyrrol-3-one intermediates |
| 08/12/2009 | CN101506161A Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
| 08/12/2009 | CN101506160A Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate |
| 08/12/2009 | CN100526287C C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 08/11/2009 | US7572869 7.9 diethyl-6,7,9-trimethyl-8-(1-phenyl-ethoxy)-1,4-dioxa-8-aza-spiro[4.5]decane initiator for polymerizing ethylenically unsaturated monomer(s); low polydispersity |
| 08/11/2009 | US7572824 Methods for minimizing thioamide impurities |
| 08/11/2009 | US7572807 3-Cycloheptyl-8-((2,6-dichlorophenoxy)methyl)H-imidazo[1,5-a]pyridine; N-((3-((2,6-Dichlorophenoxy)methyl)pyridin-2-yl)methyl)cycloheptane-carboxamide; diabetes; cardiovascular diseases, Metabolic Syndrome, inflammatory diseases |
| 08/11/2009 | US7572803 Hydrated crystalline esters of camptothecin |
| 08/11/2009 | US7572802 For central nervous system diseases, in particular Parkinson's disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder |
| 08/11/2009 | US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine |
| 08/11/2009 | US7572606 Biosyntheses of salinosporamide A and its analogs and related methods of making salinosporamide A and its analogs |
| 08/06/2009 | WO2009097567A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 08/06/2009 | WO2009097515A2 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 08/06/2009 | WO2009097309A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 08/06/2009 | WO2009096445A1 Nerve trunk cell propagation accelerator |
| 08/06/2009 | US20090198061 Camptothecin analogs and methods of preparation thereof |
| 08/06/2009 | US20090198051 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction |
| 08/06/2009 | US20090197940 CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF |
| 08/06/2009 | US20090197905 Quaternary opioid carboxamides |
| 08/06/2009 | US20090197864 Furo- and Thieno [3,2-c] Pyridines |
| 08/06/2009 | CA2712897A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 08/06/2009 | CA2712888A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 08/05/2009 | EP1805144A4 Heterocyclical chromophore architectures |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1235595B1 Integrin-mediated drug targeting |
| 08/05/2009 | CN101501038A Fused [d]pyridazin-7-ones |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522960C Thioamide derivatives as progesterone receptor modulators |
| 08/04/2009 | US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 08/04/2009 | US7569580 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid |
| 07/30/2009 | WO2009093032A1 Phthalazinone derivatives |
| 07/30/2009 | WO2009074674A3 Trisubstituted piperidines as renin inhibitors |
| 07/30/2009 | WO2009055331A3 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 07/30/2009 | US20090192322 Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates |
| 07/30/2009 | US20090192184 Crystalline Polymorphs of Topotecan Hydrochloride and Methods for the Preparation Thereof |
| 07/30/2009 | US20090192183 Oxymorphone Controlled Release Formulations |
| 07/30/2009 | US20090192170 N-((S)-1-cyclopentyl-2-oxo-2-((3aS,6aR)-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide; osteoporosis, Paget's disease, Chagas's, malaria, gingival diseases, hypercalcemia, metabolic bone disease, bone cancer and associated pain |
| 07/30/2009 | US20090192156 Phthalazinone derivatives |
| 07/30/2009 | US20090192095 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/30/2009 | CA2708175A1 Phthalazinone derivatives |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083007A1 Tiotropium salts, method for creating same and medicinal formulations containing same |
| 07/29/2009 | EP2082741A1 Novel crystal form of irinotecan hydrochloride |
| 07/29/2009 | EP2081939A1 Benzimidazole derivatives as selective acid pump inhibitors |
| 07/29/2009 | EP2081919A1 Tetrahydrofuro [3, 2-b]pyrr0l-3-0ne intermediates |
| 07/29/2009 | EP2081891A2 Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
| 07/29/2009 | EP1931679A4 Analogs of salinosporamide a |
| 07/29/2009 | EP1678166B1 Protein kinase inhibitors |
| 07/29/2009 | EP1495014B1 Flavanoids derivatives as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 07/29/2009 | CN101495486A Camptothecin derivatives with antitumor activity |
| 07/29/2009 | CN101495485A Camptothecin derivatives with antitumor activity |
| 07/29/2009 | CN101495484A Camptothecin derivatives with antitumor activity |
| 07/29/2009 | CN101495483A Isoquinuclidine derivative and method for producing 1-cyclohexene-1-carboxylic acid derivative by using the same |
| 07/29/2009 | CN101495482A Aziridinyl-epothilone compounds |
| 07/29/2009 | CN101492455A Optical pure levorotation cephalotaxine and separation purification method |
| 07/29/2009 | CN101492454A Benzimidazole derivative containing alkoxyl oxygen ethyl substituted pyridine-tetrahydrofuran |
| 07/29/2009 | CN101492453A Sulfhydryl benzimidazole derivative containing dihydrofuran-pyridine |
| 07/29/2009 | CN101492452A Sulfhydryl benzimidazole derivative containing dioxepane-pyridine |
| 07/29/2009 | CN100519573C Novel chemical substance having morphogenetic and growth-accelerating activities |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566731 2-(Chloro),4-(ethoxycarbonyl-isoprop-2,2-ylene-isoprop-2,2-ylene-oxycarbonyl-methyl),5-(methyl-thiazole; bactericides; herbicides; insecticides; fungicides; nematocides; algicides; molluscicides; construction materials; wood; clay; alkali resistance |
| 07/28/2009 | US7566727 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor |
| 07/28/2009 | US7566725 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |